Circio and Tcelltech partner on next-generation CAR-T cell therapy research
Essange Reagents and Gentian Diagnostics agree collaboration on diagnostic assay development
Haisco agrees licensing deal with Nuvectis for two drug candidates
Psilera introduces new synthetic platform to aid neuroplastogen discovery
EU approves Cenrifki for secondary progressive multiple sclerosis without relapses
Japan approves Wayrilz for immune thrombocytopenia treatment
Nura Bio completes USD73.8m Series B financing, advances clinical-stage SARM1 inhibitor programmes
Oxford BioTherapeutics reports progress in Boehringer Ingelheim partnered programmes
Sanofi appoints new global head of Research & Development Pharma
Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer
Transgene expands myvac platform into non-small cell lung cancer with TG4070
Fusion Antibodies secures Canadian patent allowance for antibody library technology
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB